Sterling Investment Advisors, Ltd. - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 3 filers reported holding ACASTI PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sterling Investment Advisors, Ltd. ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q2 2022$4,000
-33.3%
5,0000.0%0.00%
-50.0%
Q1 2022$6,0000.0%5,0000.0%0.00%0.0%
Q4 2021$6,000
-40.0%
5,0000.0%0.00%
-33.3%
Q3 2021$10,000
-54.5%
5,000
-87.5%
0.00%
-50.0%
Q2 2021$22,000
-8.3%
40,0000.0%0.01%
-25.0%
Q1 2021$24,000
+84.6%
40,0000.0%0.01%
+100.0%
Q4 2020$13,000
+62.5%
40,0000.0%0.00%
+33.3%
Q3 2020$8,000
-55.6%
40,0000.0%0.00%
-57.1%
Q2 2020$18,000
+20.0%
40,0000.0%0.01%
-12.5%
Q1 2020$15,000
-69.4%
40,000
+100.0%
0.01%
-65.2%
Q4 2019$49,000
+28.9%
20,0000.0%0.02%
+21.1%
Q3 2019$38,00020,0000.02%
Other shareholders
ACASTI PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Perceptive Advisors 236,559$594,0000.04%
INTACT INVESTMENT MANAGEMENT INC. 89,490$287,0000.01%
BANK OF MONTREAL /CAN/ 210,484$537,0000.00%
DEUTSCHE BANK AG\ 215$00.00%
Tower Research Capital LLC (TRC) 200$1,0000.00%
CITIGROUP INC 30$00.00%
MORGAN STANLEY 18$00.00%
Renaissance Technologies 20,900$53,0000.00%
ROYAL BANK OF CANADA 588$1,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 400$1,0000.00%
View complete list of ACASTI PHARMA INC shareholders